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The primary objective of this project was the drug discovery, synthesis and biological 
evaluation of a series of tyrosinase inhibitors. Chalcone skeleton was the chosen 
pharmacophore and a library of potent inhibitors of tyrosinase (polyphenol oxidase) 
were synthesized and their structure-activity (SAR) relationships were explored. 
Chalcone derivatives were synthesized by simple base catalyzed Claisen-Schmidt 
condensation of an aldehyde and an appropriate ketone in a polar solvent like methanol. 
The structures of the compounds synthesized were confirmed by 1H NMR, 13C NMR, 
FTIR and HRMS. Two compounds that are the reduction congeners of the pyridinyl 
azachalcones strongly inhibited the enzyme activity and were more potent than the 
positive control kojic acid. Two of the hydroxyazachalcones synthesized inhibited the 
diphenolase activity of tyrosinase and were identified as competitive reversible 
inhibitors and with their Ki values of 3.4 μM and 3.9 μM, respectively. This study 
showed that a more potent tyrosinase inhibitor can be obtained from 
methoxyazachalcones with a single step dealkylation reaction. A series of novel 
hydroxynaphthylchalcone compounds were synthesized and inhibited the diphenolase 
activity of tyrosinase in a dose dependent manner with much higher tyrosinase 
inhibitory activities than the positive control, kojic acid. The number and position of 
methoxy substituents on the aromatic rings appeared to be critical for cytotoxicity. Also 
placement of strongly electron-withdrawing groups such as NO2 in ring B correlated 
with increase of cytotoxic activity. This study provides valuable information in utilizing 
methoxychalcone as a lead compound for the further design and development of 
potential tyrosinase inhibitors with antimelanogenic effects. Two pyridinyl 
methoxychalcone compounds exhibited higher tyrosinase inhibitory activities (IC50 
values of 10.6 μM and 12.5μM, respectively) than the control kojic acid (IC50: 
22.83μM). Kinetic studies revealed them to act as competitive tyrosinase inhibitors. 
Both the compounds inhibited melanin production and tyrosinase activity in B16 cells. 
Docking results confirm that the active inhibitors strongly interact with mushroom 
tyrosinase residues. The current study portrays methoxychalcones with electrophilic 
character to be potent agents with antimelanogenic effects. A series of hydroxy 
substituted chalcone oxime derivatives have been synthesized and evaluated for their 
inhibitory activities on tyrosinase and melanogenesis in murine B16F10 melanoma cell 
lines. A library of 2՛-acetylpyridinyl chalconeoxime compounds was also synthesized. 
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The study portrayed the significance of an oxime moiety on the chalcone framework 
that brought about better coordination with the copper metal centers at the active site of 
mushroom tyrosinase and also exhibited stronger hydrogen bonding interactions with 
the amino acid residues. From all the compounds synthesized, a novel 2՛-acetylpyridinyl 
chalconeoxime compound exhibited the most potent tyrosinase inhibitory activity with 
an IC50 value that was found to be several times potent than the reference standard, kojic 
acid. The inhibition mechanism was competitive and was in complete agreement with 
the docking results. Furthermore, a solid-state based mechanochemical process was 
used to synthesize novel azachalcones and their oximes as tyrosinase inhibitors. Both 
the novel oxime compounds displayed competitive inhibition with their Ki values of 
5.1μM and 2.5μM, respectively. This method minimizes waste disposal problems and 
provides a simple, efficient and benign method for the synthesis of novel tyrosinase 
inhibitors for use as skin whitening agents or as anti-browning food additives. The 
effects of novel 2,3-dihydro-1H-inden-1-one chalcone-like compounds for tyrosinase 
inhibition were studied. Hydroxy substituted 1-indanone chalcone-like compounds were 
found to be significantly more potent than kojic acid. 
Assays were performed with L-DOPA as the substrate, using kojic acid, a well-known 
strong tyrosinase inhibitor as the positive control. The kinetic parameters and inhibition 
mechanisms of active tyrosinase inhibitors were illustrated with the help of Lineweaver-
Burk plots and Dixon plots. Furthermore, the experimental results were integrated with 
simulation studies using Accelrys Discovery Studio 4.5 suite. Few of the active 
tyrosinase inhibitors were further evaluated for the in vitro cytotoxic activity on B16 
F10 melanoma cell lines. The results suggested substituted chalcone derivatives to serve 
as an interesting candidate for the treatment of tyrosinase related disorders and as the 
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